Zhang Y - Search Results

1

Sintilimab maintenance therapy post first-line cytokine-induced killer cells plus chemotherapy for extensive-stage small cell lung cancer.

Ma B, Zhou Y, Shang Y, Zhang Y, Xu B, Fu X, Guo J, Yang Y, Zhang F, Zhou M, Huang H, Li F, Lin H, Zhao L, Wang Z, Gao Q. Ma B, et al. Among authors: zhang f, zhang y. Front Oncol. 2022 Sep 9;12:852885. doi: 10.3389/fonc.2022.852885. eCollection 2022. Front Oncol. 2022. PMID: 36158690 Free PMC article.

2

Factors Influencing the Efficacy of Anti-PD-1 Therapy in Chinese Patients with Advanced Melanoma.

Zhao L, Yang Y, Ma B, Li W, Li T, Han L, Zhang Y, Shang YM, Lin H, Gao Q. Zhao L, et al. Among authors: zhang y. J Oncol. 2019 Sep 26;2019:6454989. doi: 10.1155/2019/6454989. eCollection 2019. J Oncol. 2019. PMID: 31662753 Free PMC article.

3

The Sequence of Chemotherapy and Toripalimab Might Influence the Efficacy of Neoadjuvant Chemoimmunotherapy in Locally Advanced Esophageal Squamous Cell Cancer-A Phase II Study.

Xing W, Zhao L, Zheng Y, Liu B, Liu X, Li T, Zhang Y, Ma B, Yang Y, Shang Y, Fu X, Liang G, Yuan D, Qu J, Chai X, Zhang H, Wang Z, Lin H, Liu L, Ren X, Zhang J, Gao Q. Xing W, et al. Among authors: zhang j, zhang h, zhang y. Front Immunol. 2021 Dec 6;12:772450. doi: 10.3389/fimmu.2021.772450. eCollection 2021. Front Immunol. 2021. PMID: 34938292 Free PMC article. Clinical Trial.

4

High Complete Response Rate in Patients With Metastatic Renal Cell Carcinoma Receiving Autologous Cytokine-Induced Killer Cell Therapy Plus Anti-Programmed Death-1 Agent: A Single-Center Study.

Zhao L, Li T, Song Y, Yang Y, Ma B, Zhang Y, Shang Y, Xu B, Guo J, Qin P, Han L, Fu X, Lin H, Liu L, Ren X, Wang Z, Gao Q. Zhao L, et al. Among authors: zhang y. Front Immunol. 2022 Jan 4;12:779248. doi: 10.3389/fimmu.2021.779248. eCollection 2021. Front Immunol. 2022. PMID: 35058923 Free PMC article. Clinical Trial.

5

Efficacy of RetroNectin-activated cytokine-induced killer cell therapy in metastatic brain tumor patients.

Li W, Wang Y, Zhao L, Xu L, Zhang Y, Mai L, Gao Q. Li W, et al. Among authors: zhang y. Oncol Res Treat. 2015;38(4):160-5. doi: 10.1159/000380890. Epub 2015 Mar 16. Oncol Res Treat. 2015. PMID: 25877939 Clinical Trial.

6

Autologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancer.

Wang Z, Liu Y, Li R, Shang Y, Zhang Y, Zhao L, Li W, Yang Y, Zhang X, Yang T, Nie C, Han F, Liu Y, Luo S, Gao Q, Song Y. Wang Z, et al. Among authors: zhang x, zhang y. J Hematol Oncol. 2016 Feb 3;9:6. doi: 10.1186/s13045-016-0237-6. J Hematol Oncol. 2016. PMID: 26842696 Free PMC article.

7

Association of myeloid-derived suppressor cells and efficacy of cytokine-induced killer cell immunotherapy in metastatic renal cell carcinoma patients.

Wang Z, Zhang Y, Liu Y, Wang L, Zhao L, Yang T, He C, Song Y, Gao Q. Wang Z, et al. Among authors: zhang y. J Immunother. 2014 Jan;37(1):43-50. doi: 10.1097/CJI.0000000000000005. J Immunother. 2014. PMID: 24316555

8

Survival benefit from RectroNectin-activated cytokine-induced killer cells combined with chemotherapy in advanced EGFR wild-type lung adenocarcinoma.

Zhao L, Li W, Wang Z, Yang Y, Zhang Y, Shang Y, Ren X, Gao Q. Zhao L, et al. Among authors: zhang y. Immunotherapy. 2018 Mar 1;10(6):501-510. doi: 10.2217/imt-2017-0140. Immunotherapy. 2018. PMID: 29562855

9

Efficacy and safety of trastuzumab as maintenance or palliative therapy in advanced HER2-positive gastric cancer.

Fu X, Zhang Y, Yang J, Qi Y, Ming Y, Sun M, Shang Y, Yang Y, Zhu X, Gao Q. Fu X, et al. Among authors: zhang y. Onco Targets Ther. 2018 Sep 20;11:6091-6100. doi: 10.2147/OTT.S174138. eCollection 2018. Onco Targets Ther. 2018. PMID: 30275713 Free PMC article.

10

Combination of PD-1 blockade and RetroNectin^®-activated cytokine-induced killer in preheavily treated non-small-cell lung cancer: a retrospective study.

Zhao L, Han L, Zhang Y, Li T, Yang Y, Li W, Shang Y, Lin H, Gao Q. Zhao L, et al. Among authors: zhang y. Immunotherapy. 2018 Nov;10(15):1315-1323. doi: 10.2217/imt-2018-0125. Epub 2018 Oct 23. Immunotherapy. 2018. PMID: 30350739

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

257,337 results

Search Page

Filters